Nexavar significantly boosts hypertension risk: study
1/21/2008
Bayer AG and Onyx physic Inc.'s
key cancer drug Nexavar significantly raises the risk of high
blood pressure, U.S. researchers said on Tuesday.
More: - From the site
Post Comment
Entry 1 of 16100
Last Page | Next Page









